dronabinol and Local Neoplasm Recurrence
dronabinol has been researched along with Local Neoplasm Recurrence in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors
Authors | Studies |
---|---|
Brazil, L; Checketts, D; Jove, M; Miller, S; Sabel, M; Short, SC; Tayo, B; Twelves, C | 1 |
Andradas, C; Arribas, J; Bernadó-Morales, C; Bibic, L; Blasco-Benito, S; Caffarel, MM; Canals, M; Canela, EI; Caro-Villalobos, M; Casadó, V; Diez-Alarcia, R; Guzmán, M; Hernández, L; Homar-Ruano, P; Manso, L; McCormick, PJ; Moreno, E; Moreno-Bueno, G; Pérez-Gómez, E; Sánchez, C; Seijo-Vila, M; Tundidor, I; Urigüen, L | 1 |
Blázquez, C; Duarte, MJ; Galve-Roperh, I; González-Feria, L; Guzmán, M; Ravina, J; Rosa, MC; Sánchez, C; Velasco, G | 1 |
Trials
2 trial(s) available for dronabinol and Local Neoplasm Recurrence
Article | Year |
---|---|
A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cannabidiol; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Combinations; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oral Sprays; Precision Medicine; Survival Analysis; Temozolomide; Treatment Outcome | 2021 |
A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.
Topics: Adult; Aged; Biopsy; Brain Neoplasms; Cannabinoid Receptor Antagonists; Cell Proliferation; Disease Progression; Dronabinol; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Receptors, Cannabinoid; Safety; Survival Rate; Treatment Outcome; Tumor Cells, Cultured | 2006 |
Other Studies
1 other study(ies) available for dronabinol and Local Neoplasm Recurrence
Article | Year |
---|---|
Therapeutic targeting of HER2-CB
Topics: Breast Neoplasms; Cell Line, Tumor; Dronabinol; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Protein Multimerization; Proto-Oncogene Proteins c-cbl; Receptor, Cannabinoid, CB2; Receptor, ErbB-2; Signal Transduction | 2019 |